Literature DB >> 33407063

Diabetes Mellitus: An Update.

E Diamantis1.   

Abstract

Entities:  

Year:  2020        PMID： 33407063      PMCID： PMC7903501          DOI： 10.2174/1573403X1604201229120951

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN： 1573-403X


× No keyword cloud information.
  10 in total

Review 1.  SGLT2 inhibition--a novel strategy for diabetes treatment.

Authors:  Edward C Chao; Robert R Henry
Journal:  Nat Rev Drug Discov       Date:  2010-05-28       Impact factor: 84.694

Review 2.  Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?

Authors:  Bart S Ferket; Ersen B Colkesen; Jacob J Visser; Sandra Spronk; Roderik A Kraaijenhagen; Ewout W Steyerberg; M G Myriam Hunink
Journal:  Arch Intern Med       Date:  2010-01-11

Review 3.  Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis.

Authors:  Patricia M Howse; Lyudmila N Chibrikova; Laurie K Twells; Brendan J Barrett; John-Michael Gamble
Journal:  Am J Kidney Dis       Date:  2016-08-12       Impact factor: 8.860

Review 4.  Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.

Authors:  Asad Dajani; Adnan AbuHammour
Journal:  Saudi J Gastroenterol       Date:  2016 Mar-Apr       Impact factor: 2.485

Review 5.  SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study.

Authors:  Georgios Kyriakos; Lourdes V Quiles-Sanchez; Anna Garmpi; Paraskevi Farmaki; Konstantina Kyre; Spyridon Savvanis; Vasileios K Antoniou; Eleni Memi
Journal:  Curr Cardiol Rev       Date:  2020

Review 6.  Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes.

Authors:  Christos Damaskos; Alexandros Litos; Dimitrios Dimitroulis; Efstathios A Antoniou; Dimitrios Mantas; Konstantinos Kontzoglou; Nikolaos Garmpis
Journal:  Curr Cardiol Rev       Date:  2020

7.  Cardiovascular and Renal Outcomes of Incretin-based Therapies: A Review of Recent Clinical Trials.

Authors:  Georgios Kyriakos; Lourdes V Quiles-Sanchez; Anna Garmpi; Paraskevi Farmaki; Konstantina Kyre; Spyridon Gkogkos; Spyridon Savvanis; Eleni Memi
Journal:  Curr Cardiol Rev       Date:  2020

8.  Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study.

Authors: 
Journal:  Obesity (Silver Spring)       Date:  2014-01       Impact factor: 5.002

Review 9.  Cardiovascular risk assessment in patients with diabetes.

Authors:  Marcello Casaccia Bertoluci; Viviane Zorzanelli Rocha
Journal:  Diabetol Metab Syndr       Date:  2017-04-20       Impact factor: 3.320

Review 10.  Assessing Cardiovascular Risk in Patients with Diabetes: An Update.

Authors:  Christos Damaskos; Nikolaos Garmpis; Paraskevi Kollia; Georgios Mitsiopoulos; Danai Barlampa; Athanasios Drosos; Alexandros Patsouras; Nikolaos Gravvanis; Vasileios Antoniou; Alexandros Litos; Evangelos Diamantis
Journal:  Curr Cardiol Rev       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.